Name
Medicredit OÜ
Registry code
12533115
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.09.2013 (11)
Financial year
01.01-31.12
Capital
50 000.00 €
Activity
64929 - Other credit granting, except pawn shops
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Andre Liplik 25.10.1973 (51) | 50% - 25 000.00 EUR | Board member | Direct ownership | Founder |
Kristjan Gutmann 19.09.1974 (50) | 50% - 25 000.00 EUR | Board member | Direct ownership | Founder |
2019 11.10.2020 | 2020 30.06.2021 | 2021 08.07.2022 | 2022 28.06.2023 | |
---|---|---|---|---|
Total Revenue | - | - | - | - |
Net profit (loss) for the period | 28 759 € | 25 825 € | 7 315 € | -87 016 € |
Profit Margin | - | - | - | - |
Current Assets | 1 040 235 € | 1 045 808 € | 1 119 845 € | 1 083 494 € |
Fixed Assets | 726 557 € | 853 502 € | 830 407 € | 899 443 € |
Total Assets | 1 766 792 € | 1 899 310 € | 1 950 252 € | 1 982 937 € |
Current Liabilities | 202 757 € | 2 070 823 € | 1 814 450 € | 1 372 259 € |
Non Current Liabilities | 1 372 176 € | - | - | 531 894 € |
Total Liabilities | 1 574 933 € | - | - | 1 904 153 € |
Share Capital | - | - | - | - |
Equity | 191 859 € | -171 513 € | 135 802 € | 78 784 € |
Employees | 3 | 3 | 4 | 5 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 8 981.31 € | 9 581.94 € | 2 |
2023 Q4 | - | 12 331.37 € | 13 204.17 € | 2 |
2023 Q3 | - | 12 349.72 € | 13 233.86 € | 3 |
2023 Q2 | - | 12 873.01 € | 13 791.42 € | 3 |
2023 Q1 | - | 13 696.84 € | 14 682.19 € | 3 |
2022 Q4 | - | 12 061.4 € | 12 907 € | 4 |
2022 Q3 | - | 11 478.54 € | 12 290.59 € | 4 |
2022 Q2 | - | 9 880.25 € | 10 579.67 € | 4 |
2022 Q1 | - | 9 180.89 € | 9 822.27 € | 4 |
2021 Q4 | - | 9 371.28 € | 10 036.44 € | 3 |
2021 Q3 | - | 9 466.41 € | 10 120.89 € | 3 |
2021 Q2 | - | 8 688.87 € | 9 262.77 € | 4 |
2021 Q1 | - | 8 870.23 € | 9 467.02 € | 4 |
2020 Q4 | - | 7 742.22 € | 8 250.42 € | 3 |
2020 Q3 | - | 7 742.22 € | 8 250.42 € | 3 |
2020 Q2 | - | 7 742.22 € | 8 250.42 € | 3 |
2020 Q1 | - | 7 742.22 € | 8 250.42 € | 3 |